Ocugen

Ocugen is a patient-centric biotechnology company that is focused on developing and commercializing novel gene and cell therapies, and vaccines. The company's goal is to improve health and offer hope for patients across the globe, and is driven by a philosophy of "Courageous Innovation." Ocugen is currently developing a range of therapies, including a modifier gene therapy platform for the treatment of inherited retinal diseases, as well as a mucosal vaccine platform for the prevention of respiratory diseases, including COVID-19.

Ocugen operates globally with partnerships, including Bharat Biotech, the developer of the COVAXIN vaccine, and CanSinoBIO, a biopharmaceutical company focused on vaccine development. Ocugen is actively advancing its pipeline through clinical trials with its lead product OCU400 in Phase 3 clinical trials for retinitis pigmentosa and OCU410 in Phase 1/2 clinical trials for dry age-related macular degeneration. The company is also pursuing development for its cell therapy product NeoCart for the treatment of articular cartilage defects in the knee.

Ocugen is a fully integrated, patient-centric biotechnology company dedicated to discovering, developing, and commercializing novel gene and cell therapies and vaccines. They approach drug development with a sense of urgency, resolve, ingenuity, and boldness, considering patients in everything they do. Ocugen focuses on addressing unmet medical needs in the areas of blindness diseases, orthopedic conditions, and infectious diseases. Their mission is to drive courageous innovation by pursuing new approaches to medicine and developing therapies with the potential to improve health, offer hope, and even change the lives of patients.

Ocugen promotes a culture of respect, integrity, teamwork, and accountability, believing these core values are essential for fostering a community where employees feel valued and can fully contribute their unique perspectives. This inclusive environment encourages genuine expression and collaboration, driving the company's pursuit of courageous innovation while remaining focused on the needs of patients.

Ocugen believes that fostering a diverse, equitable, and inclusive work environment is crucial for driving innovation and achieving its mission of improving patient lives. They strive to create a community where team members feel comfortable being themselves and can fully contribute their unique experiences and perspectives. Ocugen is committed to respecting and valuing its employees, collaborating effectively, and ensuring inclusivity in all aspects of its operations. These principles are seen as fundamental to propelling the future of medical science while remaining patient-centric.